Selected article for: "acute respiratory syndrome and lopinavir ritonavir ribavirin"
Author: Lu, Chih-Chia; Chen, Mei-Yu; Chang, Yuh-Lih
Title: Potential therapeutic agents against COVID-19: What we know so far
  • Cord-id: 29kjytsn
  • Document date: 2020_4_21
    • ID: 29kjytsn
    Snippet: The emerging outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 continues to spread all over the world. Agents or vaccines of proven efficacy to treat or prevent human coronavirus infection are in urgent need and are being investigated vigorously worldwide. This review summarizes the current evidence of potential therapeutic agents, such as lopinavir/ritonavir, remdesivir, favipiravir, chloroquine, hydroxychloroquine, interferon, ribavir
    Document: The emerging outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 continues to spread all over the world. Agents or vaccines of proven efficacy to treat or prevent human coronavirus infection are in urgent need and are being investigated vigorously worldwide. This review summarizes the current evidence of potential therapeutic agents, such as lopinavir/ritonavir, remdesivir, favipiravir, chloroquine, hydroxychloroquine, interferon, ribavirin, tocilizumab, and sarilumab. More clinical trials are being conducted for further confirmation of the efficacy and safety of these agents in treating COVID-19.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and lung viral load: 1, 2, 3
    • additional azithromycin and lopinavir ritonavir: 1
    • lopinavir ritonavir and lotus china: 1
    • lopinavir ritonavir and lotus china trial: 1
    • lopinavir ritonavir and lpv rtv lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • lopinavir ritonavir and lpv rtv treatment: 1, 2, 3
    • lopinavir ritonavir and lung viral load: 1
    • lopinavir trial and lotus china: 1
    • lopinavir trial and lotus china trial: 1
    • lopinavir trial and lpv rtv lopinavir ritonavir: 1
    • lopinavir trial and lpv rtv treatment: 1